Synopsis
Synopsis
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
VMF
0
Listed Suppliers
0
API
0
FDF
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
1. Amdinocillin
2. Fl 1060
3. Fl-1060
4. Fl1060
5. Penicillin Hx
1. Amdinocillin
2. 32887-01-7
3. Penicillin Hx
4. Coactin
5. Hexacillin
6. Mecillinamum
7. Selexidin
8. Mecilinamo
9. Fl 1060
10. Amdinocillin [usan]
11. Ro 10-9070
12. Fl-1060
13. Mecillinam (inn)
14. Mecillinam [inn]
15. Amdinocillin (usan)
16. Ro-10-9070
17. (2s,5r,6r)-6-(azepan-1-ylmethylideneamino)-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic Acid
18. V10579p3qz
19. (2s,5r,6r)-6-[(azepan-1-ylmethylidene)amino]-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic Acid
20. Dsstox_cid_2584
21. Dsstox_rid_76643
22. Dsstox_gsid_22584
23. Mecilinamo [inn-spanish]
24. Mecillinamum [inn-latin]
25. (2s,5r,6r)-6-{[(1e)-azepan-1-ylmethylidene]amino}-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic Acid
26. 79580-20-4
27. Smr000466361
28. Coactin (tn)
29. Ro 109070
30. Cas-32887-01-7
31. Micillinam
32. Einecs 251-277-1
33. 6-((hexahydro-1h-azepin-1-yl)methyleneamino)penicillanic Acid
34. Amdinocillin [usan:usp]
35. Unii-v10579p3qz
36. (2s,5r,6r)-6-(((hexahydro-1h-azepin-1-yl)methylene)amino)-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo(3.2.0)heptane-2-carboxylic Acid
37. Ncgc00164583-01
38. Selecidin
39. Mecillinam [jan]
40. Amdinocillin [mi]
41. Chembl530
42. Mecillinam [mart.]
43. Mecillinam [who-dd]
44. Schembl34387
45. Schembl34388
46. 4-thia-1-azabicyclo(3.2.0)heptane-2-carboxylic Acid, 6-(((hexahydro-1h-azepin-1-yl)methylene)amino)-3,3-dimethyl-7-oxo-, (2s-(2alpha,5alpha,6beta))-
47. Mls000759478
48. Mls001424041
49. Mecillinam;coactin;fl 1060
50. Chembl258646
51. Dtxsid3022584
52. Amdinocillin [orange Book]
53. Hms2051e14
54. Act03258
55. Hy-a0269
56. Zinc3830206
57. Tox21_112209
58. Mfcd00056869
59. S6584
60. Zinc12469558
61. Tox21_112209_1
62. Ccg-100873
63. Db01163
64. Fs-4354
65. Nc00123
66. 6beta-[(azepan-1-ylmethylidene)amino]-2,2-dimethylpenam-3alpha-carboxylic Acid
67. Ncgc00164583-02
68. Ncgc00188988-01
69. Ac-32602
70. Cs-0017618
71. C21545
72. D02888
73. Mecillinam, Vetranal(tm), Analytical Standard
74. Ab01209740-01
75. Brd-k41051431-001-01-6
76. Q13019044
77. 6beta-{[(azepan-1-yl)methylidene]amino}-2,2-dimethylpenam-3alpha-carboxylic Acid
78. (2s,5r,6r)-6-(((e)-azepan-1-ylmethylene)amino)-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic Acid
79. (2s,5r,6r)-6-(((hexahydro-1h-azepin-1-yl)methylene)amino)-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo(3.2.0)heptane-2-carboxylic Acid.
80. (2s,5r,6r)-6-((e)-azepan-1-ylmethyleneamino)-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic Acid
81. 4-thia-1-azabicyclo(3.2.0)heptane-2-carboxylic Acid, 6-(((hexahydro-1h-azepin-1-yl)methylene)amino)-3,3-dimethyl-7-oxo-, (2s-(2.alpha.,5.alpha.,6.beta.)0-
Molecular Weight | 325.4 g/mol |
---|---|
Molecular Formula | C15H23N3O3S |
XLogP3 | 2.1 |
Hydrogen Bond Donor Count | 1 |
Hydrogen Bond Acceptor Count | 5 |
Rotatable Bond Count | 3 |
Exact Mass | 325.14601278 g/mol |
Monoisotopic Mass | 325.14601278 g/mol |
Topological Polar Surface Area | 98.5 Ų |
Heavy Atom Count | 22 |
Formal Charge | 0 |
Complexity | 500 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 3 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 1 |
Used in the treatment of urinary tract infections caused by some strains of E. coli and klebsiella and enterobacter species. Used mainly against Gram negative organisms.
Amdinocillin is a novel, semisynthetic penicillin effective against many gram-negative bacteria. The antibacterial activity of amdinocillin is derived from its ability to bind specifically and avidly to Penicillin Binding Protein-2 (PBP 2). Amdinocillin is active alone against many gram-negative organisms. Pseudomonas and non-fermenting gram-negative bacteria, however, are usually resistant. Amdinocillin, in combination with many beta-lactams, exhibits marked synergy against many enterobacteriaceae. No such synergy can be demonstrated for gram-positive organisms or pseudomonas species. Amdinocillin is not beta-lactamase stable. Organisms which produce high levels of plasma-mediated beta-lactamase are resistant to the drug. Co-administration of probenecid results in markedly elevated plasma levels of amdinocillin and delays its excretion.
Anti-Infective Agents, Urinary
Substances capable of killing agents causing urinary tract infections or of preventing them from spreading. (See all compounds classified as Anti-Infective Agents, Urinary.)
Anti-Bacterial Agents
Substances that inhibit the growth or reproduction of BACTERIA. (See all compounds classified as Anti-Bacterial Agents.)
J - Antiinfectives for systemic use
J01 - Antibacterials for systemic use
J01C - Beta-lactam antibacterials, penicillins
J01CA - Penicillins with extended spectrum
J01CA11 - Mecillinam
Absorption
Poorly absorbed if given orally.
Approximately 1 hour in patients with normal renal function. Increases to 3 to 6 hours in anephric patients.
Amdinocillin is a stong and specific antagonist of Penicillin Binding Protein-2 (PBP 2). It is active against gram negative bacteria, preventing cell wall synthesis by inhibiting the activity of PBP2. PBP2 is a peptidoglycan elongation initiating enzyme. Peptidoglycan is a polymer of sugars and amino acids that is the main component of bacterial cell walls.
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 13662
Submission : 1998-09-01
Status : Inactive
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 13639
Submission : 1998-09-01
Status : Inactive
Type : II
NDC Package Code : 66558-0207
Start Marketing Date : 2022-06-30
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
Global Sales Information
ABOUT THIS PAGE
A Amdinocillin manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Amdinocillin, including repackagers and relabelers. The FDA regulates Amdinocillin manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Amdinocillin API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Amdinocillin supplier is an individual or a company that provides Amdinocillin active pharmaceutical ingredient (API) or Amdinocillin finished formulations upon request. The Amdinocillin suppliers may include Amdinocillin API manufacturers, exporters, distributors and traders.
click here to find a list of Amdinocillin suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Amdinocillin DMF (Drug Master File) is a document detailing the whole manufacturing process of Amdinocillin active pharmaceutical ingredient (API) in detail. Different forms of Amdinocillin DMFs exist exist since differing nations have different regulations, such as Amdinocillin USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Amdinocillin DMF submitted to regulatory agencies in the US is known as a USDMF. Amdinocillin USDMF includes data on Amdinocillin's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Amdinocillin USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Amdinocillin suppliers with USDMF on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Amdinocillin as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Amdinocillin API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Amdinocillin as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Amdinocillin and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Amdinocillin NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Amdinocillin suppliers with NDC on PharmaCompass.
Amdinocillin Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Amdinocillin GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Amdinocillin GMP manufacturer or Amdinocillin GMP API supplier for your needs.
A Amdinocillin CoA (Certificate of Analysis) is a formal document that attests to Amdinocillin's compliance with Amdinocillin specifications and serves as a tool for batch-level quality control.
Amdinocillin CoA mostly includes findings from lab analyses of a specific batch. For each Amdinocillin CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Amdinocillin may be tested according to a variety of international standards, such as European Pharmacopoeia (Amdinocillin EP), Amdinocillin JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Amdinocillin USP).
LOOKING FOR A SUPPLIER?